Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region, and reduces the size of the lesion on magnetic resonance images in the acute phase after middle cerebral artery occlusion in rats.Pinokalant is a potential SARS-CoV-2 protease inhibitor for the study of stroke.
Molecular Weight:
712.83
Purity:
99.09%
CAS Number:
[149759-26-2]
Formula:
C41H48N2O9
Target:
TRP/TRPV Channel|||SARS-CoV
T70540
* VAT and and shipping costs not included. Errors and price changes excepted
